Search
Please see below for a list of search results.
The Human Tissue Authority (HTA) has produced this information to provide an overview of cryonics - the cryopreservation of whole bodies. We have worked with our public panel to find out what questions the public has about cryonics, and we have tried to answer those questions here.
The Authority is made up of a Chair and eleven Members:
To ensure that the HTA’s regulatory approach remains relevant, we actively prepare for the future. We do this through our development activities.
Our regulatory approach aims to be right-touch and in line with the principles of better regulation and the Regulators’ Code. This means that we primarily focus our regulation and resources on areas that involve an inherently greater risk to patient safety and public confidence if standards are...
Our strategic approach is based on right-touch regulation. This means being clear on the risks we are regulating, being proportionate and targeted in regulating those risks, taking into account the role of professional bodies and other regulators, and using the minimum necessary regulatory force...
In preparing this strategy, the HTA has undertaken a fundamental evaluation of the extent to which our current strategic approach protects public and professional confidence in the proper use, and quality and safety of, human tissues, cells and organs.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established by the Human Tissue Act 2004.
Our overall goal is to maintain public confidence by ensuring that the removal, storage and use of human tissue and organs are undertaken...
This document sets out the strategy for the Human Tissue Authority (HTA). It describes our strategic approach and direction, key challenges and opportunities, our strategic objectives and how we will deploy our resources on the priority areas identified over the next three...